A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (MK-7902-010) (KEYNOTE-010)

National Cheng Kung University Hospital ( Site 1603), Dawan

Chang Gung Medical Foundation. Kaohsiung Branch ( Site 1604), Kaohsiung City

Orszagos Onkologiai Intezet ( Site 2202), Budapest

Uzsoki Utcai Korhaz ( Site 2201), Budapest

Chris OBrien Lifehouse ( Site 1002), Camperdown

St George Hospital ( Site 1001), Kogarah

Borsod-Abaúj-Zemplén Megyei Központi Kórház és Egyetemi Okta-Klinikai Onkológiai és Sugárterápiás Ce, Miskolc

Debreceni Egyetem Klinikai Kozpont ( Site 2206), Debrecen

Royal Adelaide Hospital ( Site 1004), Adelaide

Jasz Nagykun Szolnok Megyei Hetenyi Geza Korhaz Rendelointezet ( Site 2200), Szolnok

Szegedi Egyetem Szent-Gyorgyi Albert Klinikai Kozpont ( Site 2207), Szeged

Weill Cornell Medicine New York Presbyterian Hospital ( Site 0040), New York

National Taiwan University Hospital ( Site 1600), Taipei

MacKay Memorial Hospital ( Site 1602), Taipei

Taipei Veterans General Hospital ( Site 1601), Taipei

Charite Universitätsmedizin Berlin Campus Benjamin Franklin ( Site 2112), Berlin

Hopital de la Timone ( Site 1903), Marseille

SUNY Upstate Medical University ( Site 0051), Syracuse

Seoul National University Bundang Hospital ( Site 1205), Seongnam-si

Hospital Nacional Guillermo Almenara Irigoyen ( Site 0700), Lima

Hospital Nacional Edgardo Rebagliati Martins ( Site 0702), Lima

Hospital Nacional Arzobispo Loayza ( Site 0703), Lima

Hospital Nacional Cayetano Heredia ( Site 0704), Lima

Ajou University Hospital ( Site 1200), Suwon

ASL Liguria 2 - Ospedale San Paolo ( Site 2401), Savona

Fondazione IRCCS Istituto Nazionale dei Tumori di Milano ( Site 2400), Milan

IEO Istituto Europeo di Oncologia ( Site 2406), Milan

ASST Santi Paolo e Carlo - Presidio Ospedaliero San Paolo ( Site 2405), Milan

Trakya Universitesi Tip Fakultesi ( Site 2801), Edirne

Inova Schar Cancer Institute ( Site 0009), Fairfax

Blue Ridge Cancer Care ( Site 0015), Blacksburg

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia ( Site 2402), Brescia

University of North Carolina- Chapel Hill ( Site 0056), Chapel Hill

Duke Cancer Center ( Site 0044), Durham

Hospital Universitario 12 de Octubre ( Site 2702), Madrid

Hospital Universitario La Paz ( Site 2706), Madrid

Northwest Georgia Oncology Centers PC ( Site 0028), Marietta

KRH Klinikum Siloah ( Site 2103), Hanover

Georgia Cancer Center at Augusta University ( Site 0013), Augusta

Memorial Regional Hospital-Memorial Cancer Institute ( Site 0069), Hollywood

Medipol Universite Hastanesi ( Site 2800), Istanbul

Ege Universitesi Tip Fakultesi Hastanesi ( Site 2804), Izmir

Istituto Oncologico Veneto ( Site 2404), Padua

Medical Park Izmir Hospital ( Site 2807), Izmir

University of Louisville, James Graham Brown Cancer Center ( Site 0045), Louisville

Hospital de Valme ( Site 2705), Seville

Keimyung University Dongsan Hospital ( Site 1203), Daegu

Inonu Universitesi Turgut Ozal Tip Merkezi ( Site 2803), Malatya

Karmanos Cancer Institute ( Site 0054), Detroit

Henry Ford Health System ( Site 0001), Detroit

Hospital Clinico Universitario Lozano Blesa ( Site 2703), Zaragoza

Universitaetsklinikum Koeln ( Site 2111), Cologne

University of Wisconsin- Madison Carbone Cancer Center ( Site 0006), Madison

Chonnam National University Hwasun Hospital ( Site 1202), Hwasun-gun

St. Vincent Frontier Cancer Center ( Site 0008), Billings

Universitaetsklinikum Frankfurt ( Site 2107), Frankfurt am Main

Washington University School of Medicine ( Site 0060), St Louis

"Hospital Universitario Dr. Jose Eleuterio Gonzalez ( Site 0602)", Monterrey

Christus Muguerza Clinica Vidriera ( Site 0607), Monterrey

University of Kansas Cancer Center ( Site 0033), Westwood

Oaxaca Site Management Organization S.C. ( Site 0603), Oaxaca City

Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0053), Omaha

Centre Leon Berard ( Site 1901), Lyon

Universitaetsklinikum Tuebingen ( Site 2108), Tübingen

Centre Henri Becquerel ( Site 1904), Rouen

Centro de Investigacion y Avances Medicos Especializados -CIAME ( Site 0604), Cancún

University of Colorado Cancer Center ( Site 0023), Aurora

Universitaetsklinikum Ulm ( Site 2102), Ulm

California Cancer Associates for Research & Excellence ( Site 0059), San Marcos

Hopital Foch ( Site 1905), Suresnes

Universitaetsklinikum Regensburg ( Site 2100), Regensburg

California Cancer Associates for Research & Excellence ( Site 0025), Fresno

Gustave Roussy ( Site 1906), Villejuif

Providence Portland Medical Center ( Site 0048), Portland

Cancer Care Northwest ( Site 0017), Spokane Valley

Peking Union Medical College Hospital ( Site 3304), Bejiing

Beijing Cancer Hospital ( Site 3314), Beining

FSCC FMBA of Russia ( Site 2603), Moscow

Jilin Cancer Hospital ( Site 3310), Changchun

Yaroslavl Regional SBIH Clinical Oncology Hospital ( Site 2605), Yaroslavl

The Third Affiliated Hospital of Harbin Medical University ( Site 3302), Harbin

Fudan University Shanghai Cancer Center ( Site 3324), Shanghai

Shanghai East Hospital ( Site 3300), Shanghai

Tianjin Medical University Cancer Hospital ( Site 3312), Tianjin

Zhejiang Cancer Hospital ( Site 3303), Hangzhou

Jiangxi Cancer Hospital ( Site 3313), Nanchang

Fujian Provincial Cancer Hospital ( Site 3326), Fuzhou

Chongqing Cancer Hospital ( Site 3327), Chongqing

Hunan Cancer Hospital ( Site 3311), Changsha

Xiangya Hospital of Central South University ( Site 3305), Changsha

Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 2609), Kazan'

Wuhan Union hospital Cancer Center ( Site 3307), Wuhan

Tongji Hospital Tongji Medical,Science & Technology ( Site 3316), Wuhan

Henan Cancer Hospital ( Site 3309), Zhengzhou

Guangxi Medical University Affiliated Tumor Hospital ( Site 3322), Nanning

Guizhou Cancer Hospital ( Site 3330), Guiyang

West China Hospital of Sichuan University ( Site 3308), Chengdu

Altay Regional Oncology Dispensary ( Site 2611), Barnaul

The First Affiliated Hospital of Xi an Jiaotong University ( Site 3328), Xi'an

Yokohama City University Hospital ( Site 1104), Yokohama

National Cancer Center Hospital East ( Site 1100), Kashiwa

Aichi Cancer Center Hospital ( Site 1113), Nagoya

Kindai University Hospital ( Site 1107), Sayama

Hiroshima University Hospital ( Site 1109), Hiroshima

University of Connecticut Health Center ( Site 0020), Farmington

Dana Farber Cancer Institute ( Site 0019), Boston

University of Michigan ( Site 0064), Ann Arbor

John Theurer Cancer Center at Hackensack University Medical Center ( Site 0002), Hackensack

Oncocentro Ceara ( Site 0412), Fortaleza

Fundacao Sao Francisco Xavier ( Site 0409), Ipatinga

ELO Pesquisa Clinica ( Site 0405), Maringá

Hospital de Passo Fundo ( Site 0401), Passo Fundo

Clinica LACKS ( Site 0402), Pelotas

Hospital Nossa Senhora da Conceição-Centro Integrado de Pesquisa em Oncologia ( Site 0414), Porto Alegre

A.C. Camargo Cancer Center ( Site 0407), São Paulo

Princess Margaret Cancer Centre ( Site 0200), Toronto

McGill University Health Centre ( Site 0206), Montreal

Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0, Québec

Universitätsklinikum Leipzig-Department for ENT ( Site 2106), Leipzig

Nagoya University Hospital ( Site 1106), Nagoya

Chiba cancer center ( Site 1110), Chiba

Hyogo Cancer Center ( Site 1112), Akashi

Kagawa University Hospital ( Site 1108), Kita-gun

Shizuoka Cancer Center Hospital and Research Institute ( Site 1105), Sunto-gun

National Hospital Organization Kyushu Medical Center ( Site 1111), Fukuoka

National Cancer Center Hospital ( Site 1102), Tokyo

The Cancer Institute Hospital of JFCR ( Site 1103), Tokyo

Tokyo Medical and Dental University Hospital ( Site 1101), Tokyo

Cryptex Investigación Clínica S.A. de C.V. ( Site 0608), Cuauhtémoc, Mexico City

Instituto Nacional de Enfermedades Neoplasicas ( Site 0701), Lima

Przychodnia Lekarska Komed ( Site 2500), Konin

Szpital Kliniczny im. Heliodora Swiecickiego Uniwers Medyczn ( Site 2509), Poznan

Centrum Onkologii im prof Franciszka Lukaszczyka ( Site 2508), Bydgoszcz

Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie ( Site 2502), Krakow

Dolnoslaskie Centrum Onkologii. ( Site 2507), Wroclaw

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Glowy i Szyi ( Site, Warsaw

Szpital Morski im. PCK. Szpitale Pomorskie Sp. Z o.o ( Site 2504), Gdynia

Narodowy Instytut Onkologii - Oddzial w Gliwicach ( Site 2506), Gliwice

Asan Medical Center ( Site 1201), Songpa-gu

The Catholic University of Korea Eunpyeong St Mary s Hospital ( Site 1204), Seoul

Hospital Duran i Reynals ( Site 2701), L'Hospitalet de Llobregat

H.U. Vall de Hebron ( Site 2700), Barcelona

Hacettepe Universitesi Tip Fakultesi ( Site 2805), Ankara

Ankara Sehir Hastanesi ( Site 2802), Ankara

Aberdeen Royal Infirmary ( Site 2905), Aberdeen

Guy's Hospital in London ( Site 2908), London

Royal Marsden NHS Foundation Trust ( Site 2910), London

Mount Vernon Cancer Centre ( Site 2902), Northwood

Royal Marsden Hospital ( Site 2904), Sutton

Nottingham City Hospital ( Site 2907), Nottingham

Taunton and Somerset Hospital ( Site 2900), Taunton

Christie NHS Foundation Trust ( Site 2903), Manchester